Citadel Securities Downgrades United Therapeutics Corp. (UTHR) to Neutral
Tweet
Share
E-mailGet Alerts UTHR Hot Sheet
Price: $501.27 -2.04%
Rating Summary:
17 Buy, 11 Hold, 1 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 8 | Down: 5 | New: 3
Rating Summary:
17 Buy, 11 Hold, 1 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 8 | Down: 5 | New: 3
Join SI Premium – FREE
Citadel Securities downgraded United Therapeutics Corp. (NASDAQ: UTHR) from Add to Neutral. PT lowered from $70 to $60.
For more ratings news on United Therapeutics Corp. click here and for the rating history of United Therapeutics Corp. click here.
Shares of United Therapeutics Corp. closed at $59.00 yesterday.
For more ratings news on United Therapeutics Corp. click here and for the rating history of United Therapeutics Corp. click here.
Shares of United Therapeutics Corp. closed at $59.00 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Goldman Sachs Downgrades Douglas AG (DOU:GR) to Sell
- RBC Capital Downgrades CareTrust REIT (CTRE) to Sector Perform
- Barclays Downgrades HelloFresh SE (HFG:GR) (HLFFF) to Underweight
Create E-mail Alert Related Categories
DowngradesSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
